New data confirm Revi’s unmatched durability, 95% patient satisfaction, and excellent safety over three years, setting a new standard in Implantable Tibial Neuromodulation SALT LAKE CITY--(BUSINESS ...
"I would run. I would exercise. I would put my hands in warm water. It would cause me to dribble," said Michele Baran about her bladder leakage problem. The 63-year-old already had tried bladder sling ...
PARK CITY, Utah--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial NeuroModulation (iTNM) and the developer of the Revi® System, today announced that new two-year data from its ...
UChicago Medicine has become the first medical center in Illinois to implant the Revi neuromodulation device, an exciting new treatment option that could offer relief for patients with urinary urgency ...
BlueWind Medical’s Revi implantable tibial neuromodulation (ITNM) system has demonstrated sustained efficacy and safety at the three-year mark in a pivotal trial in urgency urinary incontinence (UUI).
The Revi® System can be used without prior failure of more conservative treatment options for urgency urinary incontinence. The US Food and Drug Administration (FDA) has granted 510(k) clearance for ...
Dr. Kevin Benson, a urogynecologist at Sanford Health and investigator for the Altaviva device’s pivotal study, said the condition occurs when sensory wiring in the bladder wall that should normally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results